News Focus
News Focus
icon url

read_this_n0w

09/20/12 12:36 PM

#59380 RE: TaxiCaT #59379

NEUROMETRIX, INC.


--------------------------------------------------------------------------------

20-Sep-2012

Other Events, Financial Statements and Exhibits



Item 8.01 Other Events.
On September 20, 2012, NeuroMetrix, Inc. ("NeuroMetrix") reported that it has received a letter from The NASDAQ Stock Market LLC ("NASDAQ") stating that it has been granted a six month extension until March 18, 2013 of the grace period to regain compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on The NASDAQ Capital Market. During this grace period extension, NeuroMetrix common stock will continue to be listed on The NASDAQ Stock Market.

icon url

mathew633

09/20/12 1:07 PM

#59383 RE: TaxiCaT #59379

CYTK...nice movement today!
icon url

$hylo

09/20/12 1:29 PM

#59384 RE: TaxiCaT #59379

CYTK.$.90's break coming up.This will go much higher in the coming weeks.

For those who don't know,, CYTK has a strategic alliance with Amgen Inc.(AMGN)Nasdaq

Amgen Exercises Option for Exclusive License to Cytokinetics’ Cardiac Contractility Program That Includes CK-1827452
http://www.cytokinetics.com/press_releases/release/pr_1243039031

About Amgen: Amgen is the world's largest independent biotechnology firm.
http://en.wikipedia.org/wiki/Amgen